Showing 61 - 80 results of 1,171 for search 'antibody effect function', query time: 0.09s Refine Results
  1. 61

    Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity by Elaine Branstetter, Robert J. Duff, Scott Kuhns, Rupa Padaki

    Published 2021-11-01
    “…Different glycosylation patterns can affect Fc‐dependent activities, such as the ability of mAbs to bind Fcγ receptors on the effector cell surface, which is critical to immune effector functions, such as antibody‐dependent cellular cytotoxicity (ADCC). …”
    Get full text
    Article
  2. 62
  3. 63

    CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES AND IVF FAILURES by N. S. Stuleva, D. K. Khizroeva, T. Y. Mashkova, G. R. Abramyan

    Published 2016-06-01
    “…The antiphospholipid antibodies (APA) exert multiple effects on the hemostasis system causing damage to all of its protective components including the endothelial barrier, natural anticoagulant function and endogenous fibrinolysis and activating the platelet of hemostasis, which is associated with numerous obstetrical complications and infertility. …”
    Get full text
    Article
  4. 64

    Natural antibodies – facts known and unknown by Joanna Palma, Beata Tokarz-Deptuła, Jakub Deptuła, Wiesław Deptuła

    Published 2018-12-01
    “…In contrast to adaptive antibodies, natural antibodies are present in a non-immunised organism from birth, and they do not include anti-Gal antibodies and/or anti-Gal natural antibodies, which are developed as a result of the effect of the -Gal epitope and physiological flora. …”
    Get full text
    Article
  5. 65
  6. 66

    Biparatopic antibodies: therapeutic applications and prospects by David L. Niquille, Kyle M. Fitzgerald, Nimish Gera

    Published 2024-12-01
    “…This unique binding mode enables new mechanisms of action beyond monospecific and bispecific antibodies (bsAbs) that can make bpAbs effective therapeutics for various indications, including oncology and infectious diseases. …”
    Get full text
    Article
  7. 67
  8. 68

    Effectiveness of preeclampsia prognosis in pregnancy by Loskutova T.O.

    Published 2014-03-01
    “…With the purpose to develop and assess the effectiveness of prediction method of pre-eclampsia (PE) 177 women in III trimester of pregnancy were examined. …”
    Get full text
    Article
  9. 69

    Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survival by Michiel G. H. Betjes, Judith A. Kal-van Gestel, Dave Roelen, Marcia M. L. Kho, Sebastian Heidt, Annelies E. de Weerd, Jacqueline van de Wetering

    Published 2025-04-01
    “…The preDSA-associated increase in graft failure was caused primarily by an increase in the incidence of antibody-mediated rejection (ABMR), intragraft thrombosis, and primary non-function. …”
    Get full text
    Article
  10. 70
  11. 71
  12. 72

    Effects of Anti-GPIbαantibody on the expression of platelet GPIbα,CD62P and CD63 in maintenance hemodialysis patients by LUO Min-hong, YANG Tie-cheng, ZHU Lang-jing, CHEN Zhen-wei, ZENG Hai-ou, MO Cai-ju, WU Qiang, XIAO Jie

    Published 2018-01-01
    “…Objective To explore the effects of anti-platelet membrane glycoprotein Ib alpha(GPIbα)antibody on the expression of peripheral GPIbα,alpha particle membrane glycoprotein(CD62 P)and lysosomal membrane protein(CD63)in maintenance hemodialysis(MHD)patients.Methods Thirty-seven patients with chronic renal failure undergoing MHD from March 2016 to March 2018 in the Department of Nephrology in Eighth Affiliated Hospital of Sun Yat-sen University and 31 healthy people in the Physical Examination Center were enrolled in this study.Using flow cytomery,the expression of platelet member GPIbα,CD62 P and CD63 was detected before and after addition of anti-GPIbαantibody in MHD patients.Results The expression of platelet membrane GPIbαin no antibody treatment group(29.9±4.9)% was significantly lower than in control group(63.8±9.0)%and antibody treatment group(42.3±6.5)%(both P<0.01).The expression of CD62 P and CD63 in no antibody treatment group(50.9±7.5)% and(54.1±5.5)% was significantly higher than that in the control group(23.3±8.7% and 30.9±6.2%)and antibody treatment group(36.5±2.0)% and(47.2±2.2)%(P<0.01,P<0.05).Conclusions Anti-GPIbαantibody can regulate platelet function and activity by up-regulating the expression of platelet membrane GPIbα,and down-regulating the expression of CD62 P and CD63 in MHD patients,as a result to suppress adhesion and aggregation of platelets and thrombosis,and reduce the possibility of thromboembolism events in MHD patients.…”
    Get full text
    Article
  13. 73

    Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study by Xi Cheng, Zhen-feng Zheng, Yan Qi, Xin Cao, Xi-qian Gao, Ying-xin Fang, Li Wei, Wen-ya Shang, Tie-kun Yan, Jun-ya Jia, Peng-cheng Xu, Qiu-hua Gu

    Published 2025-08-01
    “…Furthermore, obinutuzumab also had a comparable efficiency in patients without response to previous rituximab treatment and patients with negative anti-PLA2R antibody. More patients in the initial therapy group had infusion-related reactions (33.3 vs. 15.0%, P=0.149), while severe infections were all occurred in the alternative therapy group, particularly those with a history of long-term immunosuppressive therapy.ConclusionsObinutuzumab, used as both initial and alternative therapy, can induce significant clinical response in patients with pMN, implying its potentially promising therapeutic effect on pMN.…”
    Get full text
    Article
  14. 74

    LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy by Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang

    Published 2024-12-01
    “…The combination of IL-2 and anti-PD-1 antibody effectively enhanced LFA-1 expression and the antitumor function of intratumoral CD8+ T cells. …”
    Get full text
    Article
  15. 75

    Effects of metabolic and organ function factors on the efficacy of radioactive iodine therapy for hyperthyroidism by Yue Hu, Shan Liu, Xiaoliang Xiong, Lixing Wang, Yinlong Zhao

    Published 2025-06-01
    “…IntroductionRecent studies suggest that metabolic and organ function indicators could influence radioactive iodine treatment (RAIT) efficacy in hyperthyroid patients, but their relationships with thyroid function remain unclear.ObjectiveThis study aims to explore the impact of these markers on RAIT efficacy and thyroid function.MethodA total of 135 hyperthyroid patients undergoing RAIT were enrolled, with biomarkers collected at baseline and 1, 3, and 6 months posttreatment. …”
    Get full text
    Article
  16. 76
  17. 77
  18. 78

    Effect of tocilizumab on pulmonary gas exchange function in patients with severe COVID-19 by D. A. Lebedev, Yu. Kh. Dolya, G. E. Savkov, M. A. Godkov, E. V. Klychnikova, А. P. Shakotko, D. A. Kosolapov, S. N. Kuznetsov, A. M. Kvasnikov, Yu. N. Vrabiy, K. V. Kiselev, V. B. Poluektova, S. S. Petrikov, K. A. Popugaev

    Published 2023-12-01
    “…Early use of monoclonal antibodies has shown promising results in cytokine storm therapy, but the effects on lung gas exchange function have not yet been studied.Aim. …”
    Get full text
    Article
  19. 79

    EFFECT OF SUBCUTANEOUS METHOTREXATE ON THE STRUCTURE AND FUNCTION OF THE VASCULAR WALL IN PATIENTS WITH RHEUMATOID ARTHRITIS by L. A. Knyazeva, N. S. Meshcherina, L. I. Knyazeva, I. I. Goryainov, M. A. Stepchenko, V. I. Ponkratov

    Published 2015-09-01
    “…Objective: to evaluate the effect of a subcutaneous methotrexate (MT) formulation (methoject), on the structure and function of the vascular wall in patients with rheumatoid arthritis (RA).Subjects and methods. …”
    Get full text
    Article
  20. 80